NCT06526442View on ClinicalTrials.gov

MRE for Diagnosis of Pancreatic Masses

RecruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

October 9, 2020

Primary Completion Date

June 1, 2025

Study Completion Date

June 1, 2026

Conditions
Pancreatic NeoplasmMagnetic Resonance Imaging
Interventions
DIAGNOSTIC_TEST

magnetic resonance imaging

all participants undergo novel MR sequences, including 3D-MRE，DCE-MRI，IVIM-DWI，T1/T2 mapping.

Trial Locations (1)

110004

RECRUITING

Shengjing hospital of china medical university, Shenyang

All Listed Sponsors
lead

Yu Shi

OTHER